Amy Rowat

Dr. Amy Rowat


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ARAmy Rowat
Amy Rowat
DJDiana E. Jaalouk
Diana E. Jaalouk
MZMonika Zwerger
Monika Zwerger
WUW. Lloyd Ung
W. Lloyd Ung
IEIrwin A. Eydelnant
Irwin A. Eydelnant
JLJan Lammerding
Jan Lammerding
Neutrophils are characterized by their distinct nuclear shape, which is thought to facilitate the transit of these cells through pore spaces less than one-fifth of their diameter. We used human promyelocytic leukemia (HL-60) cells as a model system to investigate the effect of nuclear shape in whole cell deformability. We probed neutrophil-differentiated HL-60 cells lacking expression of lamin B receptor, which fail to develop lobulated nuclei during granulopoiesis and present an in vitro model for Pelger-Huët anomaly; despite the circular morphology of their nuclei, the cells passed through micron-scale constrictions on similar timescales as scrambled controls. We then investigated the unique nuclear envelope composition of neutrophil-differentiated HL-60 cells, which may also impact their deformability; although lamin A is typically down-regulated during granulopoiesis, we genetically modified HL-60 cells to generate a subpopulation of cells with well defined levels of ectopic lamin A. The lamin A-overexpressing neutrophil-type cells showed similar functional characteristics as the mock controls, but they had an impaired ability to pass through micron-scale constrictions. Our results suggest that levels of lamin A have a marked effect on the ability of neutrophils to passage through micron-scale constrictions, whereas the unusual multilobed shape of the neutrophil nucleus is less essential.

1 October 2017 in Biophysical Journal
Verified
Journal Article
Closed access
KNKendra D. Nyberg
Kendra D. Nyberg
KHKenneth H. Hu
Kenneth H. Hu
SKSara H. Kleinman
Sara H. Kleinman
DKDamir B. Khismatullin
Damir B. Khismatullin
MBManish J. Butte
Manish J. Butte
ARAmy Rowat
Amy Rowat

1 December 2020 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
XZXuexiang Zhang
Xuexiang Zhang
TKTae-Hyung Kim
Tae-Hyung Kim
TTTimothy J Thauland
Timothy J Thauland
HLHongjun Li
Hongjun Li
FMFatemeh Sadat Majedi
Fatemeh Sadat Majedi
SLSong Li
Song Li

1 January 2016 in Integrative Biology
Verified
Journal Article
Closed access
PDF file
ANAngelyn V. Nguyen
Angelyn V. Nguyen
KNKendra D. Nyberg
Kendra D. Nyberg
MSMichael B. Scott
Michael B. Scott
AWAlia M. Welsh
Alia M. Welsh
ANAndrew H. Nguyen
Andrew H. Nguyen
ARAmy Rowat
Amy Rowat
This work determines the invasive potential of pancreatic cancer cells, and its relationship to deformability using three independent mechanotyping methods.

12 July 2022 in Biomaterials
Verified
Journal Article
Open access
SNSam C.P. Norris
Sam C.P. Norris
NKN. Stephanie Kawecki
N. Stephanie Kawecki
ADAshton R. Davis
Ashton R. Davis
KCKathleen K. Chen
Kathleen K. Chen
ARAmy Rowat
Amy Rowat
Cultured meat has potential to diversify methods for protein production, but innovations in production efficiency will be required to make cultured meat a feasible protein alternative. Microcarriers provide a strategy to culture sufficient volumes of adherent cells in a bioreactor that are required for meat products. However, cell culture on inedible microcarriers involves extra downstream processing to dissociate cells prior to consumption. Here, we present edible microcarriers that can support the expansion and differentiation of myogenic cells in a single bioreactor system. To fabricate edible microcarriers with a scalable process, we used water-in-oil emulsions as templates for gelatin microparticles. We also developed a novel embossing technique to imprint edible microcarriers with grooved topology in order to test if microcarriers with striated surface texture can promote myoblast proliferation and differentiation in suspension culture. In this proof-of-concept demonstration, we showed that edible microcarriers with both smooth and grooved surface topologies supported the proliferation and differentiation of mouse myogenic C2C12 cells in a suspension culture. The grooved edible microcarriers showed a modest increase in the proliferation and alignment of myogenic cells compared to cells cultured on smooth, spherical microcarriers. During the expansion phase, we also observed the formation of cell-microcarrier aggregates or 'microtissues' for cells cultured on both smooth and grooved microcarriers. Myogenic microtissues cultured with smooth and grooved microcarriers showed similar characteristics in terms of myotube length, myotube volume fraction, and expression of myogenic markers. To establish feasibility of edible microcarriers for cultured meat, we showed that edible microcarriers supported the production of myogenic microtissue from C2C12 or bovine satellite muscle cells, which we harvested by centrifugation into a cookable meat patty that maintained its shape and exhibited browning during cooking. These findings demonstrate the potential of edible microcarriers for the scalable production of cultured meat in a single bioreactor.

15 December 2016 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
TKTae-Hyung Kim
Tae-Hyung Kim
NGNavjot Kaur Gill
Navjot Kaur Gill
KNKendra D. Nyberg
Kendra D. Nyberg
ANAngelyn V. Nguyen
Angelyn V. Nguyen
SHSophia V. Hohlbauch
Sophia V. Hohlbauch
ARAmy Rowat
Amy Rowat
Invasion by cancer cells is a crucial step in metastasis. An oversimplified view in the literature is that cancer cells become more deformable as they become more invasive. β-adrenergic receptor (βAR) signaling drives invasion and metastasis, but the effects on cell deformability are not known. Here, we show that activation of β-adrenergic signaling by βAR agonists reduces the deformability of highly metastatic human breast cancer cells, and that these stiffer cells are more invasive in vitro. We find that βAR activation also reduces the deformability of ovarian, prostate, melanoma and leukemia cells. Mechanistically, we show that βAR-mediated cell stiffening depends on the actin cytoskeleton and myosin II activity. These changes in cell deformability can be prevented by pharmacological β-blockade or genetic knockout of the β2-adrenergic receptor. Our results identify a β2-adrenergic–Ca2+–actin axis as a new regulator of cell deformability, and suggest that the relationship between cell mechanical properties and invasion might be dependent on context.